MaaT's therapeutic restores functional microbiome in AML patients

MaaT Pharma S.A. (Lyon, France) said its MaaT Microbiome Restoration Biotherapeutic (MMRB) was well tolerated and led to functional

Read the full 194 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE